Success Stories: Engineering Cures Through Computation: EB-1A Approval for Drug Design Researcher

Client’s Testimonial:

“I truly appreciate the support and guidance provided throughout the petition preparation process. The team was professional, responsive, and thorough at every step. All my questions were addressed clearly, and the final package was well-organized and accurate. Thank you for making this process smooth and stress-free.”

On October 18^th, 2025, we received another EB-1A (Alien of Extraordinary Ability) approval for a Researcher in the Field of Computer-Aided Drug Design (Approval Notice).

General Field: Computer-Aided Drug Design

Country of Origin: India

State of Residence at the Time of Filing: Texas

Approval Notice Date: October 18^th, 2025

Processing Time: 3 months, 4 days (Premium Processing Upgrade Requested)

Case Summary:

An EB-1A (Alien of Extraordinary Ability) petition in the field of computer-aided drug design was successfully approved, recognizing the petitioner’s outstanding record of innovation in computational modeling and molecular design. North America Immigration Law Group (NAILG) prepared a detailed petition that demonstrated the petitioner’s original contributions to modern drug discovery through advanced modeling approaches and artificial intelligence-driven molecular analysis. The approval highlights the petitioner’s position among the top experts shaping the next generation of precision drug development.

The petitioner’s research focuses on advancing computational methods to accelerate and optimize the drug discovery process, reducing experimental uncertainty and improving the design of selective therapeutic candidates. His innovative approaches have significantly contributed to enhancing the accuracy and efficiency of molecular simulations, leading to progress in the discovery of more effective treatments for complex diseases.

As one expert noted, “His innovative approach testifies to his exceptional capacity to address longstanding limitations in eliminating trial-and-error synthesis and improving therapeutic selectivity, thereby highlighting the value of his ongoing research in the field of computer-aided drug design.”

Throughout his career, the petitioner has established himself as a leader in computational chemistry and molecular modeling. He has authored 23 peer-reviewed journal articles (including 10 first- or co-first-authored papers), 8 first-authored and 2 co-authored conference abstracts, and 2 preprints, which together have been cited 576 times by independent researchers worldwide.

In addition to his research achievements, the petitioner has contributed extensively to the scientific community through peer review and editorial leadership. He has completed at least 54 manuscript reviews for high-impact journals. His expertise is further recognized through invitations to judge scientific posters at international conferences, reflecting the high level of trust the research community places in his judgment and insight.

NAILG’s presentation emphasized how the petitioner’s groundbreaking computational strategies have redefined best practices in modern drug design. His EB-1A approval acknowledges not only his extraordinary scientific achievements but also his continuing potential to advance life-saving research in pharmaceutical innovation. NAILG is proud to have represented this exceptional researcher and to have contributed to securing this important success.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.